Literature DB >> 20335007

First-episode schizophrenia patients neuropsychologically within the normal limits: evidence of deterioration in speed of processing.

César González-Blanch1, José Manuel Rodríguez-Sánchez, Rocío Pérez-Iglesias, Gema Pardo-García, Obdulia Martínez-García, José Luis Vázquez-Barquero, Benedicto Crespo-Facorro.   

Abstract

In apparent contradiction to the notion of cognitive impairment as a core feature of schizophrenia, some studies have described a subgroup of patients neuropsychologically within normal limits. It remains to be determined whether this subgroup has intact cognitive functioning or a higher premorbid functioning that attenuates the evidence of deterioration. Out of a total of 111 patients with FES or schizophreniform disorder, 25 (23%) were classified as cognitive normal (CN) according to criteria based on performance in six basic cognitive dimensions and an overall composite score, and their cognitive profile was compared with that of 28 controls. The CN subgroup had better social premorbid adjustment and had a higher premorbid IQ than the cognitive impaired subgroup. There were no differences in the other pretreatment variables examined. The CN subgroup performed similarly to controls in the cognitive dimensions, including sustained attention, verbal memory and executive functions. These profiles remained mostly unaltered after controlling for premorbid IQ. The cognitive deterioration index, calculated by ratio of performance in general knowledge and vocabulary abilities to a measure of processing speed , showed that both patient subgroups had similar levels of deterioration and that this was significantly different to that of controls. Although FES patients performed within normal limits and better than cognitive impaired patients in a processing speed task, they did nevertheless display a pattern of deterioration in processing speed (in relation to their premorbid IQ) equivalent to that of those with marked impairments. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335007     DOI: 10.1016/j.schres.2010.02.1072

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  12 in total

1.  Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study.

Authors:  Shelly L Babin; Ashley J Hood; Adel A Wassef; Nina G Williams; Saumil S Patel; Anne B Sereno
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-06-13       Impact factor: 5.067

2.  Level and pattern of neuropsychological functioning in early-onset psychoses.

Authors:  D-M Walker; P J Standen
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-10-12       Impact factor: 4.785

3.  The NIH Toolbox Pattern Comparison Processing Speed Test: Normative Data.

Authors:  Noelle E Carlozzi; Jennifer L Beaumont; David S Tulsky; Richard C Gershon
Journal:  Arch Clin Neuropsychol       Date:  2015-05-29       Impact factor: 2.813

4.  Semantic association fMRI impairments represent a potential schizophrenia biomarker.

Authors:  Sharna D Jamadar; Godfrey D Pearlson; Kasey M O'Neil; Michal Assaf
Journal:  Schizophr Res       Date:  2013-02-08       Impact factor: 4.939

5.  Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.

Authors:  A McCleery; J Ventura; R S Kern; K L Subotnik; D Gretchen-Doorly; M F Green; G S Hellemann; K H Nuechterlein
Journal:  Schizophr Res       Date:  2014-06-02       Impact factor: 4.939

6.  Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients.

Authors:  Rosa Ayesa-Arriola; José Manuel Rodríguez-Sánchez; Esther Setién Suero; Lauren E Reeves; Rafael Tabarés-Seisdedos; Benedicto Crespo-Facorro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-01-14       Impact factor: 5.270

7.  An Association Study on the Cognitive Function and the Cerebral Grey Matter Volume of Patients with First-Episode Schizophrenia.

Authors:  Xinyue Zhang; Jingjing Yao; Yiding Lv; Xiaoxin Zhao; Yuan Li; Yuxiu Sui; Dai Zhiping
Journal:  Shanghai Arch Psychiatry       Date:  2018-06-25

8.  The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients.

Authors:  Juana Gómez-Benito; Georgina Guilera; Óscar Pino; Emilio Rojo; Rafael Tabarés-Seisdedos; Gemma Safont; Anabel Martínez-Arán; Manuel Franco; Manuel J Cuesta; Benedicto Crespo-Facorro; Miguel Bernardo; Eduard Vieta; Scot E Purdon; Francisco Mesa; Javier Rejas
Journal:  BMC Psychiatry       Date:  2013-05-06       Impact factor: 3.630

9.  Neurocognitive normality in schizophrenia revisited.

Authors:  R Walter Heinrichs; Farena Pinnock; Eva Muharib; Leah Hartman; Joel Goldberg; Stephanie McDermid Vaz
Journal:  Schizophr Res Cogn       Date:  2015-11-19

10.  Deficits in Auditory and Visual Sensory Discrimination Reflect a Genetic Liability for Psychosis and Predict Disruptions in Global Cognitive Functioning.

Authors:  Ian S Ramsay; Michael-Paul Schallmo; Bruno Biagianti; Melissa Fisher; Sophia Vinogradov; Scott R Sponheim
Journal:  Front Psychiatry       Date:  2020-07-07       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.